EPMA Journal

Aims & Scope

PMA Journal is a journal of predictive, preventive and personalized medicine (PPPM).

The journal provides expert viewpoints and research on medical innovations and advanced healthcare using predictive diagnostics, targeted preventive measures and personalized patient treatments.

The journal is indexed by PubMed, Embase and Scopus.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	5.9
2024	6.00

Journal Rank

Year	Value
2024	2623

Journal Citation Indicator

Year	Value
2024	822

SJR (SCImago Journal Rank)

Year	Value
2024	1.421

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	57

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Drug delivery systems: Advanced technologies potentially applicable in personalized treatments

  Citation: 334

  Authors: Jorge F., Paula C., Patricia, Rosemeyre, Ana C., Joana R., Maria H.

• Medicine in the early twenty-first century: paradigm and anticipation - EPMA position paper 2016

  Citation: 322

  Authors: Olga, Babak, Giovanni, Wei, Rostyslav, Marko, Kurt, Mahmood S., Vincenzo

• Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine

  Citation: 307

  Authors: Suzanne, Eilidh, Amalia

• Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine

  Citation: 285

  Authors: Elisabeth, Kurt

• The primary vascular dysregulation syndrome: implications for eye diseases

  Citation: 237

  Authors: Josef, Katarzyna, Andreas J

• General Report & Recommendations in Predictive, Preventive and Personalised Medicine 2012: White Paper of the European Association for Predictive, Preventive and Personalised Medicine

  Citation: 227

  Authors: Olga, Vincenzo

• Impaired wound healing: facts and hypotheses for multi-professional considerations in predictive, preventive and personalised medicine

  Citation: 211

  Authors: Eden, Kristina, Olga

• The crucial role of multiomic approach in cancer research and clinically relevant outcomes

  Citation: 196

  Authors: Miaolong, Xianquan

• Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control

  Citation: 177

  Authors: Ramūnas

• Taiwan’s healthcare report 2010

  Citation: 170

  Authors: Willie Sai

---